Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Lessons learned from use of highly active antiretroviral therapy in Africa.

Akileswaran C, Lurie MN, Flanigan TP, Mayer KH.

Clin Infect Dis. 2005 Aug 1;41(3):376-85. Review.

2.
3.

API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.

Gupta SB, Pujari SN, Joshi SR, Patel AK; AIDS Society of India Guidelines Development Committee..

J Assoc Physicians India. 2006 Jan;54:57-74. Review.

PMID:
16649742
4.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
5.

Current and future antiretroviral treatment options in paediatric HIV infection.

Giaquinto C, Morelli E, Fregonese F, Rampon O, Penazzato M, de Rossi A, D'Elia R.

Clin Drug Investig. 2008;28(6):375-97. Review.

PMID:
18479179
6.

Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world.

Frentz D, Boucher CA, van de Vijver DA.

AIDS Rev. 2012 Jan-Mar;14(1):17-27. Review.

PMID:
22297501
7.

Antiretroviral treatment in resource-poor settings: public health research priorities.

Jaffar S, Govender T, Garrib A, Welz T, Grosskurth H, Smith PG, Whittle H, Bennish ML.

Trop Med Int Health. 2005 Apr;10(4):295-9. Review.

8.

Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review.

Beard J, Feeley F, Rosen S.

AIDS Care. 2009 Nov;21(11):1343-56. doi: 10.1080/09540120902889926. Review.

PMID:
20024710
9.

What policymakers should know about drug resistance and adherence in the context of scaling-up treatment of HIV infection.

Lange JM, Perriens J, Kuritzkes D, Zewdie D.

AIDS. 2004 Jun;18 Suppl 3:S69-74. Review.

PMID:
15322488
10.

[HIV drug resistance and optimization of antiviral treatment in resource-poor countries].

Doualla-Bell F, Turner D, Loemba H, Petrella M, Brenner B, Wainberg MA.

Med Sci (Paris). 2004 Oct;20(10):882-6. Review. French.

11.

Patterns of neuroAIDS in Africa.

Tadesse T, Langford D, Manji K, Mehari E.

J Neurovirol. 2005;11 Suppl 1:22-6. Review.

PMID:
15960237
12.

Implementing operational research to scale-up access to antiretroviral therapy for HIV infection: lessons learned from the Cameroonian experience.

Boyer S, Koulla-Shiro S, Abé C, Spire B, Moatti JP.

Curr Opin HIV AIDS. 2011 Jul;6(4):239-44. doi: 10.1097/COH.0b013e3283478757. Review.

PMID:
21537170
13.

Viral load monitoring as a tool to reinforce adherence: a systematic review.

Bonner K, Mezochow A, Roberts T, Ford N, Cohn J.

J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):74-8. doi: 10.1097/QAI.0b013e31829f05ac. Review.

PMID:
23774877
Items per page

Supplemental Content

Support Center